Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4275
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaskesen, Fatih-
dc.contributor.authorCezairli, Burak-
dc.date.accessioned2024-03-15T08:35:44Z-
dc.date.available2024-03-15T08:35:44Z-
dc.date.issued2023-
dc.identifier.citationTaskesen, F., Cezairli, B. (2023). Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility. Cranio-J. Craniomandib. Sleep Pract., 41(5), 423-431. https://doi.org/10.1080/08869634.2020.1861887en_US
dc.identifier.issn0886-9634-
dc.identifier.issn2151-0903-
dc.identifier.urihttp://dx.doi.org/10.1080/08869634.2020.1861887-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000599353400001-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4275-
dc.descriptionWoS Categories: Dentistry, Oral Surgery & Medicineen_US
dc.descriptionWeb of Science Index: Science Citation Index Expanded (SCI-EXPANDED)en_US
dc.descriptionResearch Areas: Dentistry, Oral Surgery & Medicineen_US
dc.description.abstractObjective: The aim of this study was to compare the efficacy of dextrose prolotherapy in conjunction with arthrocentesis and dextrose prolotherapy alone in the management of symptomatic TMJ hypermobility. Methods: Twenty-four patients suffering from TMJ symptomatic hypermobility received 10% dextrose injections for three sessions at four-week intervals. Twelve patients (P group) received prolotherapy alone; the other 12 (PA group) also underwent a single arthrocentesis session. Patients were evaluated for maximal incisal opening, maximal incisal opening without pain, pain at rest, pain during chewing function, TMJ sound, and locking episode frequency. Results: Pain scores were significantly reduced in both groups, and the locking episode frequency was decreased to a greater extent in the PA than the P group, at both the short and long terms. Conclusion: Prolotherapy is effective in the management of TMJ hypermobility. However, prolotherapy with arthrocentesis may be superior to prolotherapy alone in the management of TMJ hypermobility.en_US
dc.language.isoengen_US
dc.publisherTAYLOR & FRANCIS LTD-ABINGDONen_US
dc.relation.isversionof10.1080/08869634.2020.1861887en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectProlotherapy, arthrocentesis, temporomandibular jointen_US
dc.subjectDEXTROSE PROLOTHERAPY, AUTOLOGOUS BLOOD, DOUBLE-BLIND, INJECTION, EMINECTOMY, PLACEBOen_US
dc.titleEfficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobilityen_US
dc.typearticleen_US
dc.relation.journalCRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICEen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0002-1196-9840en_US
dc.identifier.volume41en_US
dc.identifier.issue5en_US
dc.identifier.startpage423en_US
dc.identifier.endpage431en_US
Appears in Collections:Ağız, Diş ve Çene Cerrahisi

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.